Sentinel Lymph Node Biopsy: An Overview

  • Amanda L. Kong
  • Rosa F. Hwang


The original concept of sentinel lymph node biopsy (SLNB) is attributed to Cabanas, who described use of the technique for the treatment and staging of penile cancer. The concept of SLNB was revived 15 years later by Morton et al., in their work using lymphatic mapping with blue dye in patients with melanoma. Ultimately, Alex and Krag introduced use of the gamma probe with radioactive colloid injections, and Giuliano et al. applied SLNB with blue-dye-based lymphatic mapping to breast surgery, influencing the techniques we use today. Sentinel node biopsy is now considered the standard of care in managing the axilla in patients with clinically negative regional nodes.


Sentinel Lymph Node Biopsy Axillary Lymph Node Dissection Prophylactic Mastectomy Positive Sentinel Lymph Node Sentinel Lymph Node Metastasis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Cabanas RM. An approach for the treatment of penile carcinoma. Cancer. 1977;39(2):456–66.PubMedCrossRefGoogle Scholar
  2. 2.
    Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127(4):392–9.PubMedCrossRefGoogle Scholar
  3. 3.
    Alex JC, Krag DN. Gamma-probe guided localization of lymph nodes. Surg Oncol. 1993;2(3):137–43.PubMedCrossRefGoogle Scholar
  4. 4.
    Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994;220(3):391–8; discussion 398–401.Google Scholar
  5. 5.
    Pelosi E, Bello M, Giors M, et al. Sentinel lymph node detection in patients with early-stage breast cancer: comparison of periareolar and subdermal/peritumoral injection techniques. J Nucl Med. 2004;45(2):220–5.PubMedGoogle Scholar
  6. 6.
    Solorzano CC, Ross MI, Delpassand E, et al. Utility of breast sentinel lymph node biopsy using day-before-surgery injection of high-dose 99mTc-labeled sulfur colloid. Ann Surg Oncol. 2001;8(10):821–7.PubMedCrossRefGoogle Scholar
  7. 7.
    Schwartz GF, Giuliano AE, Veronesi U. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19-22, 2001, Philadelphia, Pennsylvania. Cancer. 2002;94(10):2542–51.PubMedCrossRefGoogle Scholar
  8. 8.
    Krag DN, Anderson SJ, Julian TB, et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol. 2007;8(10):881–8.PubMedCrossRefGoogle Scholar
  9. 9.
    Consensus Statement on Guidelines for performing sentinel lymph node dissection in breast cancer. Fourth Revision. 2007. Accessed 29 November 2007.
  10. 10.
    Mansel RE, Fallowfield L, Kissin M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst. 2006;98(9):599–609 [erratum appears in J Natl Cancer Inst. 2006;98(12):876].Google Scholar
  11. 2010.
    Hwang RF, Krishnamurthy S, Hunt KK, et al. Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer. Ann Surg Oncol. 2003;10(3):248–54.PubMedCrossRefGoogle Scholar
  12. 12.
    Van Zee KJ, Manasseh DM, Bevilacqua JL, et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol. 2003;10(10):201040–51.CrossRefGoogle Scholar
  13. 13.
    Lambert L, Ayers G, Hwang R, et al. Validation of a breast cancer nomogram for predicting nonsentinel lymph node metastases after a positive sentinel node biopsy. Ann Surg Oncol. 2006;13(3):310–20.PubMedCrossRefGoogle Scholar
  14. 14.
    Bevilacqua JL, Kattan MW, Fey JV, Cody 3rd HS, Borgen PI, Van Zee KJ. Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation. J Clin Oncol. 2007;25(24):3670–9.PubMedCrossRefGoogle Scholar
  15. 15.
    Hwang RF, Gonzalez-Angulo AM, Yi M, et al. Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection. Cancer. 2007;20100(4):723–30.CrossRefGoogle Scholar
  16. 16.
    Naik AM, Fey J, Gemignani M, et al. The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures. Ann Surg. 2004;240(3):462–8; discussion 468–71.Google Scholar
  17. 17.
    Zakaria S, Degnim AC, Kleer CG, et al. Sentinel lymph node biopsy for breast cancer: how many nodes are enough? J Surg Oncol. 2007;96(7):554–9.PubMedCrossRefGoogle Scholar
  18. 18.
    Gradishar WJ. Male breast cancer. In: Harris JR, Lippman ME, Morrow M, Osborne CK, editors. Diseases of the Breast. Philadelphia: Lippincott Williams & Wilkins; 2000. p. 661–7.Google Scholar
  19. 19.
    Boughey JC, Bedrosian I, Meric-Bernstam F, et al. Comparative analysis of sentinel lymph node operation in male and female breast cancer patients. J Am Coll Surg. 2006;203(4):475–80.PubMedCrossRefGoogle Scholar
  20. 20.
    Lyman GH, Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005;23(30):7703–20.PubMedCrossRefGoogle Scholar
  21. 21.
    Mabry H, Giuliano AE, Silverstein MJ. What is the value of axillary dissection or sentinel node biopsy in patients with ductal carcinoma in situ? Am J Surg. 2006;192(4):455–7.PubMedCrossRefGoogle Scholar
  22. 22.
    Goldflam K, Hunt KK, Gershenwald JE, et al. Contralateral prophylactic mastectomy. Predictors of significant histologic findings. Cancer. 2004;101(9):1977–86.PubMedCrossRefGoogle Scholar
  23. 23.
    Boughey JC, Cormier JN, Xing Y, et al. Decision analysis to assess the efficacy of routine sentinel lymphadenectomy in patients undergoing prophylactic mastectomy. Cancer. 2007;20100(2010):2542–50.CrossRefGoogle Scholar
  24. 24.
    Port ER, Fey J, Gemignani ML, et al. Reoperative sentinel lymph node biopsy: a new option for patients with primary or locally recurrent breast carcinoma. J Am Coll Surg. 2002;195(2):167–72.PubMedCrossRefGoogle Scholar

Copyright information

© Springer New York 2010

Authors and Affiliations

  1. 1.Department of Surgical OncologyUniversity of Texas M. D. Anderson Cancer Center, University of TexasHoustonUSA

Personalised recommendations